1
|
Holierook M, Henstra MJ, Dolman DJ, Chekanova EV, Veenis L, Beijk MAM, de Winter RJ, Baan J, Vis MM, Lemkes JS, Snaterse M, Henriques JPS, Delewi R. Higher Edmonton Frail Scale prior to transcatheter Aortic Valve Implantation is related to longer hospital stay and mortality. Int J Cardiol 2024; 399:131637. [PMID: 38065322 DOI: 10.1016/j.ijcard.2023.131637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/02/2023] [Revised: 11/30/2023] [Accepted: 12/03/2023] [Indexed: 12/31/2023]
Abstract
BACKGROUND International guidelines for the management of valvular heart disease recommend frailty assessment prior to Transcatheter Aortic Valve Implantation (TAVI), however there is no consensus how to assess frailty. We investigated whether frailty status assessed with the Edmonton Frail Scale (EFS, range 0-17 points) relates to length of stay (LOS), short- and long-term mortality and adverse outcomes after TAVI. METHODS In this study we included 357 patients between April 2016 till December 2018. EFS was assessed at baseline. Patients were classified into low (0-3), intermediate (4-7) or high frailty status (8-17). LOS was defined as the number of days between admission and discharge. Mortality data were obtained up to four years after TAVI. Adverse events were defined by Valve Academic Research Consortium (VARC)-2 criteria and collected <30 days after TAVI. RESULTS Patients with higher frailty status had longer median LOS (days (IQR): low 5 (3), intermediate 6 (4) and high 7 (5), p < 0.001) and higher mortality: low vs intermediate vs high at 30 days 0.5%, 2.2%, 7.0% (p = 0.050), 1 year 3.7%, 10.0%, 15.2% (p = 0.052), 2 years 9.2%, 17.8%, 31.7% (p = 0.003), 3 years 17.2%, 24.0, 47.0% (p = 0.001) and 4 years 19.6%, 30.8%, 55.6% (p < 0.001). Frail patients received more often a pacemaker (2.6%, 6.6%, 13.5%, p = 0.048). CONCLUSION In clinical practice, the EFS is a useful tool to screen for frailty in TAVI patients. This tool may possibly be expanded to determine benefit versus harm-risk in these patients and whether specific pre-procedurally interventions are needed in order to reduce mortality.
Collapse
Affiliation(s)
- Marja Holierook
- Amsterdam UMC location University of Amsterdam, Cardiology, Meibergdreef 9, Amsterdam, the Netherlands.
| | - Marieke J Henstra
- Amsterdam UMC location University of Amsterdam, Internal Medicine Geriatrics, Meibergdreef 9, Amsterdam, the Netherlands
| | - Doortje J Dolman
- Amsterdam UMC location University of Amsterdam, Cardiology, Meibergdreef 9, Amsterdam, the Netherlands
| | - Elena V Chekanova
- Amsterdam UMC location University of Amsterdam, Cardiology, Meibergdreef 9, Amsterdam, the Netherlands
| | - Linda Veenis
- Amsterdam UMC location University of Amsterdam, Cardiology, Meibergdreef 9, Amsterdam, the Netherlands
| | - Marcel A M Beijk
- Amsterdam UMC location University of Amsterdam, Cardiology, Meibergdreef 9, Amsterdam, the Netherlands
| | - Robbert J de Winter
- Amsterdam UMC location University of Amsterdam, Cardiology, Meibergdreef 9, Amsterdam, the Netherlands
| | - Jan Baan
- Amsterdam UMC location University of Amsterdam, Cardiology, Meibergdreef 9, Amsterdam, the Netherlands
| | - Marije M Vis
- Amsterdam UMC location University of Amsterdam, Cardiology, Meibergdreef 9, Amsterdam, the Netherlands
| | - Jorrit S Lemkes
- Amsterdam UMC location University of Amsterdam, Cardiology, Meibergdreef 9, Amsterdam, the Netherlands
| | - Marjolein Snaterse
- Amsterdam UMC location University of Amsterdam, Cardiology, Meibergdreef 9, Amsterdam, the Netherlands
| | - José P S Henriques
- Amsterdam UMC location University of Amsterdam, Cardiology, Meibergdreef 9, Amsterdam, the Netherlands
| | - Ronak Delewi
- Amsterdam UMC location University of Amsterdam, Cardiology, Meibergdreef 9, Amsterdam, the Netherlands
| |
Collapse
|
2
|
Burzotta F, Graziani F, Trani C, Aurigemma C, Bruno P, Lombardo A, Liuzzo G, Nesta M, Lanza GA, Romagnoli E, Locorotondo G, Leone AM, Pavone N, Spalletta C, Pelargonio G, Sanna T, Aspromonte N, Cavaliere F, Crea F, Massetti M. Clinical Impact of Heart Team Decisions for Patients With Complex Valvular Heart Disease: A Large, Single-Center Experience. J Am Heart Assoc 2022; 11:e024404. [PMID: 35621200 PMCID: PMC9238748 DOI: 10.1161/jaha.121.024404] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Background A multidisciplinary approach might be pivotal for the management of patients with valvular heart disease (VHD), but clinical outcome data are lacking. Methods and Results At our institution, since 2014, internal guidelines recommended heart team consultations for patients with VHD. The clinical/echocardiographic characteristics, treatment recommendations, performed treatment, and early clinical outcomes of consecutive, hospitalized patients with VHD undergoing heart team evaluation were collected. Surgical risk was prospectively assessed by the EuroSCORE II and STS‐PROM. The primary end point of the study was early mortality. A total of 1004 patients with VHD with high clinical complexity (mean age, 75 years; mean EuroSCORE II, 9.4%; mean STS‐PROM, 5.6%; 48% ischemic heart disease; 29% chronic kidney disease, 9% oncologic/hematologic diseases) were enrolled. The heart team recommended an interventional treatment for 807 (80%) patients and conservative management for 197 (20%) patients. Management crossovers occurred in only 5% of patients. The recommended intervention was cardiac surgery for 230 (23%) patients, percutaneous treatment in 516 (51%) patients, and hybrid treatment in 61 (6%) patients. Early mortality occurred in 24 patients (2.4%) and was independently predicted by aortic stenosis, left ventricular ejection fraction, pulmonary artery systolic pressure, and conservative management recommendation. In patients referred to treatment, observed early mortality (1.7%) was significantly lower (P<0.001) than expected on the bases of both the STS‐PROM (5.2%) and EuroSCORE II (9.7%). Conclusions Within the limitations of its single‐center and observational design, the present study suggests that heart team–based management of patients with complex VHD is feasible and allows referral to a wide spectrum of interventions with promising early clinical results.
Collapse
Affiliation(s)
- Francesco Burzotta
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italia.,Università Cattolica del Sacro Cuore Roma Italia
| | | | - Carlo Trani
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italia.,Università Cattolica del Sacro Cuore Roma Italia
| | | | - Piergiorgio Bruno
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italia.,Università Cattolica del Sacro Cuore Roma Italia
| | - Antonella Lombardo
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italia.,Università Cattolica del Sacro Cuore Roma Italia
| | - Giovanna Liuzzo
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italia.,Università Cattolica del Sacro Cuore Roma Italia
| | - Marialisa Nesta
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italia
| | - Gaetano Antonio Lanza
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italia.,Università Cattolica del Sacro Cuore Roma Italia
| | - Enrico Romagnoli
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italia
| | | | | | - Natalia Pavone
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italia.,Università Cattolica del Sacro Cuore Roma Italia
| | | | - Gemma Pelargonio
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italia.,Università Cattolica del Sacro Cuore Roma Italia
| | - Tommaso Sanna
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italia.,Università Cattolica del Sacro Cuore Roma Italia
| | - Nadia Aspromonte
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italia.,Università Cattolica del Sacro Cuore Roma Italia
| | - Franco Cavaliere
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italia.,Università Cattolica del Sacro Cuore Roma Italia
| | - Filippo Crea
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italia.,Università Cattolica del Sacro Cuore Roma Italia
| | - Massimo Massetti
- Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italia.,Università Cattolica del Sacro Cuore Roma Italia
| |
Collapse
|
3
|
van Beek-Peeters JJAM, van den Ende Z, Faes MC, de Vos AJBM, van Geldorp MWA, Van den Branden BJL, van der Meer BJM, Minkman MMN. Decision making in treatment of symptomatic severe aortic stenosis: a survey study in Dutch heart centres. Neth Heart J 2022; 30:423-428. [PMID: 35380417 PMCID: PMC9402830 DOI: 10.1007/s12471-022-01676-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/17/2022] [Indexed: 11/30/2022] Open
Abstract
Aim To provide insight into the basic characteristics of decision making in the treatment of symptomatic severe aortic stenosis (SSAS) in Dutch heart centres with specific emphasis on the evaluation of frailty, cognition, nutritional status and physical functioning/functionality in (instrumental) activities of daily living [(I)ADL]. Methods A questionnaire was used that is based on the European and American guidelines for SSAS treatment. The survey was administered to physicians and non-physicians in Dutch heart centres involved in the decision-making pathway for SSAS treatment. Results All 16 Dutch heart centres participated. Before a patient case is discussed by the heart team, heart centres rarely request data from the referring hospital regarding patients’ functionality (n = 5), frailty scores (n = 0) and geriatric consultation (n = 1) as a standard procedure. Most heart centres ‘often to always’ do their own screening for frailty (n = 10), cognition/mood (n = 9), nutritional status (n = 10) and physical functioning/functionality in (I)ADL (n = 10). During heart team meetings data are ‘sometimes to regularly’ available regarding frailty (n = 5), cognition/mood (n = 11), nutritional status (n = 8) and physical functioning/functionality in (I)ADL (n = 10). After assessment in the outpatient clinic patient cases are re-discussed ‘sometimes to regularly’ in heart team meetings (n = 10). Conclusions Dutch heart centres make an effort to evaluate frailty, cognition, nutritional status and physical functioning/functionality in (I)ADL for decision making regarding SSAS treatment. However, these patient data are not routinely requested from the referring hospital and are not always available for heart team meetings. Incorporation of these important data in a structured manner early in the decision-making process may provide additional useful information for decision making in the heart team meeting. Supplementary Information The online version of this article (10.1007/s12471-022-01676-w) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
| | - Z van den Ende
- Department of Geriatrics, Amphia Hospital, Breda, The Netherlands
| | - M C Faes
- Department of Geriatrics, Amphia Hospital, Breda, The Netherlands
| | | | - M W A van Geldorp
- Department of Cardiothoracic Surgery, Amphia Hospital, Breda, The Netherlands
| | | | - B J M van der Meer
- TIAS School for Business and Society, Tilburg University, Tilburg, The Netherlands
- Board of Directors, Catharina Hospital, Eindhoven, The Netherlands
| | - M M N Minkman
- TIAS School for Business and Society, Tilburg University, Tilburg, The Netherlands
- Vilans, Centre of Expertise for Long-term Care, Utrecht, The Netherlands
| |
Collapse
|
4
|
Changes in demographics, treatment and outcomes in a consecutive cohort who underwent transcatheter aortic valve implantation between 2005 and 2020. Neth Heart J 2022; 30:411-422. [PMID: 35212972 PMCID: PMC9402869 DOI: 10.1007/s12471-022-01662-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/13/2021] [Indexed: 11/24/2022] Open
Abstract
Introduction Transcatheter aortic valve implantation (TAVI) has matured to the treatment of choice for most patients with aortic stenosis (AS). We sought to identify trends in patient and procedural characteristics, and clinical outcomes in all patients who underwent TAVI between 2005 and 2020. Methods A single-centre analysis was performed on 1500 consecutive patients who underwent TAVI, divided into three tertiles (T) of 500 patients treated between November 2005 and December 2014 (T1), January 2015 and May 2018 (T2) and June 2018 and April 2020 (T3). Results Over time, mean age and gender did not change (T1 to T3: 80, 80 and 79 years and 53%, 55% and 52% men, respectively), while the Society of Thoracic Surgeons risk score declined (T1: 4.5% to T3: 2.7%, p < 0.001). Use of general anaesthesia also declined over time (100%, 24% and 1% from T1 to T3) and transfemoral TAVI remained the default approach (87%, 94% and 92%). Median procedure time and contrast volume decreased significantly (186, 114 and 56 min and 120, 100 and 80 ml, respectively). Thirty-day mortality (7%, 4% and 2%), stroke (7%, 3% and 3%), need for a pacemaker (19%, 22% and 8%) and delirium (17%, 12% and 8%) improved significantly, while major bleeding/vascular complications did not change (both approximately 9%, 6% and 6%). One-year survival was 80%, 88% and 92%, respectively. Conclusion Over our 15 years’ experience, patient age remained unchanged but the patient risk profile became more favourable. Simplification of the TAVI procedure occurred in parallel with major improvement in outcomes and survival. Bleeding/vascular complications and the need for pacemaker implantation remain the Achilles’ heel of TAVI. Supplementary Information The online version of this article (10.1007/s12471-022-01662-2) contains supplementary material, which is available to authorized users.
Collapse
|
5
|
Jonik S, Marchel M, Pędzich-Placha E, Huczek Z, Kochman J, Ścisło P, Czub P, Wilimski R, Hendzel P, Opolski G, Grabowski M, Mazurek T. Heart Team for Optimal Management of Patients with Severe Aortic Stenosis-Long-Term Outcomes and Quality of Life from Tertiary Cardiovascular Care Center. J Clin Med 2021; 10:jcm10225408. [PMID: 34830690 PMCID: PMC8623928 DOI: 10.3390/jcm10225408] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2021] [Revised: 11/16/2021] [Accepted: 11/18/2021] [Indexed: 11/16/2022] Open
Abstract
Background: This retrospective study was proposed to investigate outcomes of patients with severe aortic stenosis (AS) after implementation of various treatment strategies following dedicated Heart Team (HT) decisions. Methods: Primary and secondary endpoints and quality of life during a median follow-up of 866 days of patients with severe AS qualified after HT discussion to: optimal medical treatment (OMT) alone, OMT and transcather aortic valve replacement (TAVR) or OMT and surgical aortic valve replacement (SAVR) were evaluated. As the primary endpoint composite of all-cause mortality, non-fatal disabling strokes and non-fatal rehospitalizations for AS were considered, while other clinical outcomes were determined as secondary endpoints. Results: From 2016 to 2019, 176 HT meetings were held, and a total of 482 participants with severe AS and completely implemented HT decisions (OMT, TAVR and SAVR for 79, 318 and 85, respectively) were included in the final analysis. SAVR and TAVR were found to be superior to OMT for primary and all secondary endpoints (p < 0.05). Comparing interventional strategies only, TAVR was associated with reduced risk of acute kidney injury, new onset of atrial fibrillation and major bleeding, while the superiority of SAVR for major vascular complications and need for permanent pacemaker implantation was observed (p < 0.05). The quality of life assessed at the end of follow-up was significantly better for patients who underwent TAVR or SAVR than in OMT-group (p < 0.05). Conclusions: We demonstrated that after careful implementation of HT decisions interventional strategies compared to OMT only provide superior outcomes and quality of life for patients with AS.
Collapse
Affiliation(s)
- Szymon Jonik
- 1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland; (S.J.); (E.P.-P.); (Z.H.); (J.K.); (P.Ś.); (G.O.); (M.G.); (T.M.)
| | - Michał Marchel
- 1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland; (S.J.); (E.P.-P.); (Z.H.); (J.K.); (P.Ś.); (G.O.); (M.G.); (T.M.)
- Correspondence: ; Tel.: +48-22-599-19-58; Fax: +48-22-599-19-57
| | - Ewa Pędzich-Placha
- 1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland; (S.J.); (E.P.-P.); (Z.H.); (J.K.); (P.Ś.); (G.O.); (M.G.); (T.M.)
| | - Zenon Huczek
- 1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland; (S.J.); (E.P.-P.); (Z.H.); (J.K.); (P.Ś.); (G.O.); (M.G.); (T.M.)
| | - Janusz Kochman
- 1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland; (S.J.); (E.P.-P.); (Z.H.); (J.K.); (P.Ś.); (G.O.); (M.G.); (T.M.)
| | - Piotr Ścisło
- 1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland; (S.J.); (E.P.-P.); (Z.H.); (J.K.); (P.Ś.); (G.O.); (M.G.); (T.M.)
| | - Paweł Czub
- Department of Cardiac Surgery, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland; (P.C.); (R.W.); (P.H.)
| | - Radosław Wilimski
- Department of Cardiac Surgery, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland; (P.C.); (R.W.); (P.H.)
| | - Piotr Hendzel
- Department of Cardiac Surgery, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland; (P.C.); (R.W.); (P.H.)
| | - Grzegorz Opolski
- 1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland; (S.J.); (E.P.-P.); (Z.H.); (J.K.); (P.Ś.); (G.O.); (M.G.); (T.M.)
| | - Marcin Grabowski
- 1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland; (S.J.); (E.P.-P.); (Z.H.); (J.K.); (P.Ś.); (G.O.); (M.G.); (T.M.)
| | - Tomasz Mazurek
- 1st Department of Cardiology, Medical University of Warsaw, Banacha 1a Str., 01-267 Warsaw, Poland; (S.J.); (E.P.-P.); (Z.H.); (J.K.); (P.Ś.); (G.O.); (M.G.); (T.M.)
| |
Collapse
|
6
|
Çelik M, Durko AP, Bekkers JA, Oei FBS, Mahtab EAF, Bogers AJJC. Outcomes of surgical aortic valve replacement over three decades. J Thorac Cardiovasc Surg 2021; 164:1742-1751.e8. [PMID: 34053741 DOI: 10.1016/j.jtcvs.2021.04.064] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/25/2020] [Revised: 04/09/2021] [Accepted: 04/12/2021] [Indexed: 12/31/2022]
Abstract
OBJECTIVE The study objective was to analyze temporal changes in baseline and procedural characteristics and long-term survival of patients undergoing surgical aortic valve replacement over a 30-year period. METHODS A retrospective analysis of patients undergoing surgical aortic valve replacement between 1987 and 2016 in the Erasmus Medical Center (Rotterdam, The Netherlands) was conducted. Patient baseline and procedural characteristics were analyzed in periods according to the date of surgical aortic valve replacement (period A: 1987-1996; B: 1997-2006; C: 2007-2016). Survival status was determined using the Dutch National Death Registry. Relative survival was obtained by comparing the survival after surgical aortic valve replacement with the survival of the age-, sex-, and year-matched general population. RESULTS Between 1987 and 2016, 4404 patients underwent SAVR. From period A to C, the mean age increased from 63.9 ± 11.2 years to 66.2 ± 12.3 years (P < .001), and the prevalence of diabetes mellitus, hypertension, hypercholesterolemia, previous myocardial infarction, and previous stroke at baseline increased (P values for trend for all < .001). The prevalence of concomitant procedures increased from 42.4% in period A to 48.3% in period C (P = .004). Bioprosthesis use increased significantly (18.8% in period A vs 67.1% in period C, P < .001). Mean survival after surgical aortic valve replacement was 13.8 years. Relative survival at 20 years in the overall cohort was 60.4% (95% confidence interval, 55.9-65.2) and 73.8% (95% confidence interval, 67.1-81.1) in patients undergoing isolated primary surgical aortic valve replacement. CONCLUSIONS Patient complexity has been continuously increasing over the last 30 years, yet long-term survival after surgical aortic valve replacement remains high compared with the age-, sex-, and year-matched general population.
Collapse
Affiliation(s)
- Mevlüt Çelik
- Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Andras P Durko
- Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Jos A Bekkers
- Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Frans B S Oei
- Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Edris A F Mahtab
- Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
| | - Ad J J C Bogers
- Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands
| |
Collapse
|
7
|
Smits PC. Plan-Do-Study-Act in transcatheter aortic valve replacement. Neth Heart J 2021; 29:186-187. [PMID: 33725264 PMCID: PMC7991051 DOI: 10.1007/s12471-021-01559-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/01/2021] [Indexed: 11/15/2022] Open
Affiliation(s)
- P C Smits
- Department of Cardiology, Maasstad Hospital, Rotterdam, The Netherlands.
| |
Collapse
|
8
|
Khalil KN, Boukhris M, Badreddine M, Ben Ali W, Stevens L, Masson J, Potvin J, Gobeil J, Noiseux N, Khairy P, Forcillo J. Changes in outcomes over time in intermediate‐risk patients treated for severe aortic stenosis. J Card Surg 2020; 35:3422-3429. [DOI: 10.1111/jocs.15063] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2020] [Accepted: 09/02/2020] [Indexed: 11/26/2022]
Affiliation(s)
- Khalil N. Khalil
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal Montréal Canada
- Division of Cardiology Centre Hospitalier de l'Université de Montréal Montréal Canada
| | - Marouane Boukhris
- Department of Cardiac Surgery Centre Hospitalier de Université de Montréal Montréal Canada
| | - Malek Badreddine
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal Montréal Canada
- Division of Cardiology Centre Hospitalier de l'Université de Montréal Montréal Canada
| | - Walid Ben Ali
- Division of Cardiology Centre Hospitalier de l'Université de Montréal Montréal Canada
| | - Louis‐Mathieu Stevens
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal Montréal Canada
- Division of Cardiology Centre Hospitalier de l'Université de Montréal Montréal Canada
| | - Jean‐Bernard Masson
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal Montréal Canada
- Department of Cardiac Surgery Centre Hospitalier de Université de Montréal Montréal Canada
| | - Jeannot Potvin
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal Montréal Canada
- Department of Cardiac Surgery Centre Hospitalier de Université de Montréal Montréal Canada
| | - Jean‐François Gobeil
- Department of Cardiac Surgery Centre Hospitalier de Université de Montréal Montréal Canada
| | - Nicolas Noiseux
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal Montréal Canada
- Division of Cardiology Centre Hospitalier de l'Université de Montréal Montréal Canada
| | - Paul Khairy
- Department of Cardiology Institut de Cardiologie de Montréal Montréal Canada
| | - Jessica Forcillo
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal Montréal Canada
- Division of Cardiology Centre Hospitalier de l'Université de Montréal Montréal Canada
| |
Collapse
|
9
|
de Jaegere P, de Ronde M, den Heijer P, Weger A, Baan J. The history of transcatheter aortic valve implantation: The role and contribution of an early believer and adopter, the Netherlands. Neth Heart J 2020; 28:128-135. [PMID: 32780343 PMCID: PMC7419393 DOI: 10.1007/s12471-020-01468-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
This paper describes the history of transcatheter aortic valve implantation (TAVI) from its preclinical phase during which visionary pioneers developed its concept and prototype valves against strong head wind to first application in clinical practice (2002) and the clinical and scientific role of an early believer and adopter, the Netherlands (2005).
Collapse
Affiliation(s)
- P de Jaegere
- Department of Cardiology, Erasmus University, Rotterdam, The Netherlands.
| | - M de Ronde
- Department of Cardiology, Erasmus University, Rotterdam, The Netherlands
| | - P den Heijer
- Department of Cardiology, Amphia Hospital, Breda, The Netherlands
| | - A Weger
- Department of Cardiothoracic Surgery, Leiden University Medical Centre, Leiden, The Netherlands
| | - J Baan
- Department of Cardiology, Amsterdam AMC, University of Amsterdam, Amsterdam, The Netherlands
| |
Collapse
|
10
|
Affiliation(s)
- P den Heijer
- Heart Centre, Amphia Hospital, Breda, The Netherlands.
| |
Collapse
|